Terms: = Cervical cancer AND ERBB4, MGC138404, 2066, ENSG00000178568, Q15303, p180erbB4, HER4
20 results:
1. Prognostic value of MRI-determined cervical lymph node size in nasopharyngeal carcinoma.
Huang CL; Chen Y; Guo R; Mao YP; Xu C; Tian L; Liu LZ; Lin AH; Sun Y; Ma J; Tang LL
Cancer Med; 2020 Oct; 9(19):7100-7106. PubMed ID: 32794334
[TBL] [Abstract] [Full Text] [Related]
2. Biasing human epidermal growth factor receptor 4 (her4) tyrosine kinase signaling with antibodies: Induction of cell death by antibody-dependent her4 intracellular domain trafficking.
Lanotte R; Garambois V; Gaborit N; Larbouret C; Musnier A; Martineau P; Pèlegrin A; Chardès T
Cancer Sci; 2020 Jul; 111(7):2508-2525. PubMed ID: 32415868
[TBL] [Abstract] [Full Text] [Related]
3. A pan-HER-targeted approach for recurrent or late-stage cervical cancer therapy: mechanisms, recent advances, and clinical prospects.
Liu Y; An Q; Zhao X
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4123-4131. PubMed ID: 32373948
[TBL] [Abstract] [Full Text] [Related]
4. Projections up to 2100 and a budget optimisation strategy towards cervical cancer elimination in China: a modelling study.
Xia C; Hu S; Xu X; Zhao X; Qiao Y; Broutet N; Canfell K; Hutubessy R; Zhao F
Lancet Public Health; 2019 Sep; 4(9):e462-e472. PubMed ID: 31493843
[TBL] [Abstract] [Full Text] [Related]
5. Phosphatidylinositol 3-kinase pathway genomic alterations in 60,991 diverse solid tumors informs targeted therapy opportunities.
Millis SZ; Jardim DL; Albacker L; Ross JS; Miller VA; Ali SM; Kurzrock R
Cancer; 2019 Apr; 125(7):1185-1199. PubMed ID: 30582752
[TBL] [Abstract] [Full Text] [Related]
6. The projected timeframe until cervical cancer elimination in Australia: a modelling study.
Hall MT; Simms KT; Lew JB; Smith MA; Brotherton JM; Saville M; Frazer IH; Canfell K
Lancet Public Health; 2019 Jan; 4(1):e19-e27. PubMed ID: 30291040
[TBL] [Abstract] [Full Text] [Related]
7. Incidence of cervical high-grade squamous intraepithelial lesions in HIV-1-infected women with no history of cervical pathology: up to 17 years of follow-up.
Videla S; Tarrats A; Ornelas A; Badia R; Castella E; Alcalde C; Chamorro A; Esté JA; Clotet B; Sirera G
Int J STD AIDS; 2019 Jan; 30(1):56-63. PubMed ID: 30170532
[TBL] [Abstract] [Full Text] [Related]
8. cervical small cell neuroendocrine tumor mutation profiles via whole exome sequencing.
Cho SY; Choi M; Ban HJ; Lee CH; Park S; Kim H; Kim YS; Lee YS; Lee JY
Oncotarget; 2017 Jan; 8(5):8095-8104. PubMed ID: 28042953
[TBL] [Abstract] [Full Text] [Related]
9. Genetic variations in EGFR and erbb4 increase susceptibility to cervical cancer.
Ma D; Hovey RL; Zhang Z; Fye S; Huettner PC; Borecki IB; Rader JS
Gynecol Oncol; 2013 Nov; 131(2):445-50. PubMed ID: 23927961
[TBL] [Abstract] [Full Text] [Related]
10. [Rate of cervical intraepithelial neoplasia before HPV vaccination, Alpes-Maritimes 2006].
Bailly L; Bongain A; Mariné Barjoan E; Sattonnet C; Saos J; Durant ML; Mousteou F; Pradier C
Gynecol Obstet Fertil; 2011 Oct; 39(10):549-53. PubMed ID: 21856202
[TBL] [Abstract] [Full Text] [Related]
11. Macrophages may promote cancer growth via a GM-CSF/HB-EGF paracrine loop that is enhanced by CXCL12.
Rigo A; Gottardi M; Zamò A; Mauri P; Bonifacio M; Krampera M; Damiani E; Pizzolo G; Vinante F
Mol Cancer; 2010 Oct; 9():273. PubMed ID: 20946648
[TBL] [Abstract] [Full Text] [Related]
12. Measurement of mRNA of 11 biomarkers by RT-PCR to detect lymph node involvement in cervical cancer.
Samouelian V; Revillion F; Alloy N; Lhotellier V; Leblanc E; Peyrat JP
Int J Biol Markers; 2008; 23(2):74-82. PubMed ID: 18629779
[TBL] [Abstract] [Full Text] [Related]
13. The prognostic significance of human epidermal growth factor receptor correlations in squamous cell cervical carcinoma.
Fuchs I; Vorsteher N; Bühler H; Evers K; Sehouli J; Schaller G; Kümmel S
Anticancer Res; 2007; 27(2):959-63. PubMed ID: 17465227
[TBL] [Abstract] [Full Text] [Related]
14. Gene profiling in Pap-cell smears of high-risk human papillomavirus-positive squamous cervical carcinoma.
Manavi M; Hudelist G; Fink-Retter A; Gschwandtler-Kaulich D; Pischinger K; Czerwenka K
Gynecol Oncol; 2007 May; 105(2):418-26. PubMed ID: 17306351
[TBL] [Abstract] [Full Text] [Related]
15. Correlation between human epidermal growth factor receptor family (EGFR, HER2, HER3, her4), phosphorylated Akt (P-Akt), and clinical outcomes after radiation therapy in carcinoma of the cervix.
Lee CM; Shrieve DC; Zempolich KA; Lee RJ; Hammond E; Handrahan DL; Gaffney DK
Gynecol Oncol; 2005 Nov; 99(2):415-21. PubMed ID: 16157365
[TBL] [Abstract] [Full Text] [Related]
16. Co-localization of multiple ErbB receptors in stratified epithelium of oral squamous cell carcinoma.
Bei R; Pompa G; Vitolo D; Moriconi E; Ciocci L; Quaranta M; Frati L; Kraus MH; Muraro R
J Pathol; 2001 Oct; 195(3):343-8. PubMed ID: 11673832
[TBL] [Abstract] [Full Text] [Related]
17. The expression of HPV-16 E5 protein in squamous neoplastic changes in the uterine cervix.
Chang JL; Tsao YP; Liu DW; Huang SJ; Lee WH; Chen SL
J Biomed Sci; 2001; 8(2):206-13. PubMed ID: 11287752
[TBL] [Abstract] [Full Text] [Related]
18. New insights into anti-HER-2 receptor monoclonal antibody research.
Kumar R; Mandal M; Vadlamudi R
Semin Oncol; 2000 Dec; 27(6 Suppl 11):84-91; discussion 92-100. PubMed ID: 11236033
[TBL] [Abstract] [Full Text] [Related]
19. [Prognostic value of cell heterogeneity in cervical cancer determined by digital image analyzer of DNA content].
Pete I; Gaudi I; Szerdahelyi A; Tóth E; Pulay T; Szentirmay Z
Orv Hetil; 2000 Oct; 141(40):2187-92. PubMed ID: 11064570
[TBL] [Abstract] [Full Text] [Related]
20. The expression of type I growth factor receptors in the squamous neoplastic changes of uterine cervix.
Chang JL; Tsao YP; Liu DW; Han CP; Lee WH; Chen SL
Gynecol Oncol; 1999 Apr; 73(1):62-71. PubMed ID: 10094882
[TBL] [Abstract] [Full Text] [Related]